Single-Arm Study to Assess the Efficacy of UVADEX (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS CELLEX Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Methoxsalen (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Mallinckrodt Inc.; Therakos
- 02 Aug 2018 Planned End Date changed from 1 Jan 2021 to 1 Jan 2022.
- 02 Aug 2018 Planned primary completion date changed from 1 Jan 2021 to 1 Jan 2022.
- 12 Apr 2018 Planned End Date changed from 1 Oct 2018 to 1 Jan 2021.